InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
50%
T+90 mean return
-5.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Karam Sammy, Vice-Président Senior. Director active across 1 company, notably Abbott Laboratories. Aggregated, 9 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1.6m. History available since 3 August 2021. The latest transaction was filed on 28 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
12,322 shares0Common shares without par valueSEC:0001415889-23-003909:0
4,200 shares@ US$108.7511.8% of flowCommon shares without par valueSEC:0001415889-23-000127:0
13,238 shares0Common shares without par valueSEC:0001415889-22-002194:0
4,700 shares@ US$140.004915.9% of flowCommon shares without par valueSEC:0001415889-21-006264
4,700 shares@ US$140.00490.0003% mcap18.0% of flowCommon shares without par valueSEC:0001415889-21-006264:0
8,000 shares@ US$75.9014.2% of flowCommon shares without par valueSEC:0001415889-21-004019
8,000 shares@ US$75.900.0002% mcap16.1% of flowCommon shares without par valueSEC:0001415889-21-004019:0
8,000 shares@ US$75.900.0002% mcap15.9% of flowCommon shares without par valueSEC:0001415889-21-003804:0
8,000 shares@ US$75.9014.0% of flowCommon shares without par valueSEC:0001415889-21-003804
9 of 9 declarations
About Karam Sammy
Sammy Karam is the Senior Vice President at Abbott Laboratories. He is responsible for managing operations and strategic development for the company. With significant experience in the pharmaceutical sector, Sammy Karam contributes to process optimization and growth at Abbott Laboratories. His leadership is essential for achieving the company's objectives.
